Buscar en la RAPD Online
RAPD 2026
VOL 49
N2 Marzo - Abril 2026
N2 March - April

Datos de la publicación


Esophageal squamous cell carcinoma and Lynch Syndrome: a coincidental association.


Abstract

Lynch syndrome is the most common cause of hereditary colorectal cancer and is primarily associated with colorectal and endometrial tumours. Its association with oesophageal squamous cell carcinoma is exceptional and scarcely documented; here, we describe a case with this distinctive feature.

Keywords: esophageal squamous cell carcinoma, Lynch's syndrome.


CORRESPONDENCE

Ana Plaza Fernández

Torrecárdenas University Hospital. Almería.

04009 Almería.

anplafdez@gmail.com

CITE THIS WORK

Plaza Fernández A, Sánchez Tripiana M, Hallouch Toutouh S. Esophageal squamous cell carcinoma and Lynch Syndrome: a coincidental association. RAPD 2026;49(2):68-69. DOI: 10.37352/2026492.6

Introduction

Lynch syndrome is an autosomal dominant disorder caused by mutations in DNA repair genes, which predisposes individuals to an increased risk of neoplasms, primarily colorectal and endometrial cancers. Its association with squamous cell carcinoma of the esophagus is rare and not yet well established; we present a clinical case that highlights this possible correlation.

Clinical case

A 68-year-old patient with no history of substance abuse, a history of endometrial carcinoma treated at age 55 and currently disease-free, was evaluated for de novo constitutional syndrome. A computed tomography (CT) scan was performed, revealing a pancreatic neoplasm that was unresectable due to vascular involvement (Figure 1). Subsequently, an endoscopic ultrasound with fine-needle aspiration (FNA) biopsy was performed, and histological analysis was consistent with squamous cell carcinoma. Given the rare nature of this neoplasm, the case was presented to a multidisciplinary committee, where a possible pancreatic metastasis from an occult squamous cell carcinoma was proposed. A positron emission tomography-computed tomography (PET-CT) scan was requested, which revealed a hypermetabolic lesion in the distal esophagus; biopsy confirmed primary esophageal squamous cell carcinoma with microsatellite instability. Genetic testing was requested, revealing a pathogenic mutation in the PMS2 gene, which confirmed the diagnosis of Lynch syndrome.

Figure 1

A heterogeneous lesion originating from the pancreas, without associated dilation of the bile duct or the duct of Wirsung, which completely encases the proximal third of the branches of the celiac trunk and the origin of the superior mesenteric artery, and comes into contact with the portal vein over an angle of >180°.

imagenes/ct_fig1.png

Discussion

Lynch syndrome is the most common cause of hereditary colorectal cancer and is associated with an increased risk of developing other cancers, such as those of the endometrium, stomach, pancreas, urinary tract, and ovary[1]. However, the association between Lynch syndrome and squamous cell carcinoma of the esophagus is rare and has not yet been fully documented[2],[3].

Squamous cell carcinoma of the esophagus is primarily associated with environmental factors such as tobacco and alcohol use, or chronic esophagitis. Nevertheless, some studies suggest a possible link to alterations in DNA repair mechanisms. In this context, the presence of mutations in PMS2, as in the case presented, could indicate an additional underlying mechanism that promotes esophageal carcinogenesis[2],[3].

Although the association between Lynch syndrome and esophageal squamous cell carcinoma remains uncertain, this case underscores the importance of considering less common neoplasms in the context of hereditary cancer predisposition syndromes. Likewise, the early identification of criteria suggestive of hereditary cancer and the performance of genetic testing facilitate better risk stratification and appropriate follow-up, which positively impacts the management of the patient and their family members[1].

Bibliography

1 

Hodan R, Gupta S, Weiss JM, Axell L, Burke CA, et al. Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024;22(10):695-711. doi:10.6004/jnccn.2024.0061.

2 

Cao H, Peisu S, Zhang W, Fang G, Li Y, et al. A pan-cancer statistical study of microsatellite instability and Lynch syndrome–associated mismatch repair genes germline mutations. J Clin Oncol. 2023;41:10593. doi:10.1200/JCO.2023.41.16_suppl.10593.

3 

Wang HH, Kats-Ugurlu G, Sijmons RH, Kluiver JL, Commandeur-Jan SZ, et al. Metastatic mismatch repair deficient oesophageal squamous cell carcinoma leading to diagnosis of Lynch syndrome with a complete response to nivolumab treatment. Virchows Arch. 2025 Sep 19. doi:10.1007/s00428-025-04269-1.

This work is licensed under

CC BY-NC-ND 4.0 Between January 1st, 2024 and January 14th, 2026
This work is licensed under

CC BY 4.0 Since January 15th, 2026